Cleaning validation is an important process in the pharmaceutical industry to ensure product safety and purity. It involves documenting evidence that an approved cleaning procedure will adequately clean equipment used in pharmaceutical production. The cleaning validation process includes planning, execution, analytical testing, and reporting phases. A cross-functional team plans the validation program, which involves grouping products, equipment, cleaning agents, and methods. Sampling techniques like swab and rinse sampling are used in the execution phase. Acceptance criteria are established and analytical tests are performed on samples to verify cleaning levels. A validation report documents the results and conclusions to obtain approval. Revalidation may be required if any changes are made to the cleaning process.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This presentation includes detail about cleaning levels,equipments for cleaning validation , steps for cleaning method validation and analytical method validation used for cleaning.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This presentation includes detail about cleaning levels,equipments for cleaning validation , steps for cleaning method validation and analytical method validation used for cleaning.
Cleaning validation is one of the major and critical activity in pharmaceutical operations
The four basic requirement of cGmp are …
Identity
Safety*
Strength
Purity*
Qualification of Friability Test Apparatus.pptxGNIPST
Brief description of qualification of laboratory testing apparatus : Friability Test Apparatus.
share it with your friends also if they faced problem about this topic.
Thank you
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
Cleaning validation is one of the major and critical activity in pharmaceutical operations
The four basic requirement of cGmp are …
Identity
Safety*
Strength
Purity*
Qualification of Friability Test Apparatus.pptxGNIPST
Brief description of qualification of laboratory testing apparatus : Friability Test Apparatus.
share it with your friends also if they faced problem about this topic.
Thank you
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
The subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has continued to receive a large amount of attention from regulators, companies and customers alike.
The integration of Cleaning Validation within an effective Quality System supported by Quality Risk Management Processes should give assurance that API Manufacturing Operations are performed in such a way that Risks to patients related to cleaning validation are understood, assessed for impact and are mitigated as necessary.
It is important that the requirements for the finished manufacturing companies are not transferred back in the process to active pharmaceutical ingredient manufacturers without consideration for the different processes that take place at this stage.
This presentation covers the requirements of Cleaning Validation for a Multipurpose API Manufactuirng Plant
Bioburden Validation Strategy for Cleaning Validationangelsalaman
This presentation is based on the article published by Pharmaceutical Technology (USA) entitled “BIOBURDEN METHOD SUITABILITY FOR CLEANING AND SANITATION MONITORING: HOW FAR WE HAVE TO GO?”, Aug 2010. by Angel L. Salaman-Byron
In this presentation from CPhi 2014, Elise Gallais outlines the guidelines for cleaning validation: and focuses on analytical methods and their validation.
Our objective is to demonstrate how Total Organic Carbon (TOC) analysis is a quick, accurate screening alternative for critiquing cleaning validation samples.
Typical laboratory testing includes the development and implementation of analytical methods that test for residues of previously manufactured products, cleaning detergents, chemicals, solvents, byproducts, degradants, and microbial contaminates (from wet environments after the cleaning validation). TOC analysis has become one of a series of analytical methods used to assess the effectiveness of a cleaning validation. Almost any residual compound can be detected if three non-specific analytical (screening) tests are applied to a cleaning validation: TOC (for organics characteristics– carbon), pH (for acid/base characteristics) and conductivity (for ionic characteristics).
Analytical precision and analyte recovery for cleaning agents (detergents) and other possible contaminates that may be found in clean in place (CIP) solutions will be investigated for TOC. TOC analysis demonstrated equivalent or better correlation to cleaning validation compounds in comparison to traditional analytical methods. Some qualities that make TOC a viable part of a cleaning validation includes: high sensitivity, high recovery of samples, non-specific measurement, ease of use (little method development), minimal interferences and cost effectiveness.
This presentation will focus on the characteristics and benefits of TOC with general implementation guidelines for performing cleaning validation. By taking a proactive approach to one’s cleaning validation program, one can guarantee effective performance while minimizing downtime.
Cleaning validation is a procedure of establishing evidence that cleaning processes for
manufacturing equipment prevents product contamination. Cleaning validation should be
properly documented to demonstrate Current Good Manufacturing Practice (CGMP) for
finished pharmaceuticals.
◦ Cleaning procedures should normally be validated. In general, cleaning validation should be
directed to situations or process steps where contamination or carryover of materials poses the
greatest risk to API quality.
◦ For example, in early production it may be unnecessary to validate equipment cleaning
procedures where residues are removed by subsequent purification steps.
◦ Validation of cleaning procedures should reflect actual equipment usage patterns. If various
APIs or intermediates are manufactured in the same equipment and the equipment is cleaned
by the same process, a representative intermediate or API can be selected for cleaning
validation.
◦ This selection should be based on the solubility and difficulty of cleaning and the calculation
of residue limits based on potency, toxicity, and stability.
Pharmaceutical Validation: Role in Phamaceutical Industrykaunainfathema1
This is a brief presentation on various concepts under Pharamaceutical Validation including its importance, scope, history, authorities, types of validation, VMP; along with the ICH and WHO Guidelines to be followed for Calibration of Equipments.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
2. DEFINITION
Cleaning validation – It is a documented evidence
which provides high degree of assurance that an
approved cleaning procedure will provide
equipment that is suitable for processing of
pharmaceutical products for API.
2
3. IMPORTANCE OF CLEANING VALIDATION
Cleaning validation is heart of pharmaceutical
activity .
Related to safety and purity of the product
Level of cleanliness is achieved by cleaning
procedure which depend upon its cleaning
validation method if performed confidently ,method
produces reproducible results .
3
8. • Coordinating entire team
• Monitoring process
• Compiling data
• Preparing final reports
Validation
officer
• Prepare SOP’s for new
process or equipment
• Assist in collection of
validation data
Production
department
officer
• Prepare SOP’s for the
cleaning of new packaging
• Assist in the collection of
validation data
Packaging
department
CLEANINGVALIDATIONTEAM
8
9. • Defining requirements.
• Training
• Informing relevant departments
Maintenance
department
• Perform microbiological testing
• Provide data for active ingredient and
cleaning agent
Quality control
department
• Reviewing & approving the validation
• Assessment in case of deviations
Quality
assurance
department
• Defining the process to be validated
• Provide technical assistance
Product
development
laboratory
CLEANINGVALIDATIONTEAM
9
11. PRODUCT GROUPING
Worst case product
Least soluble Most toxic
Highest
cocentration
Others
Subdivide it
Formulation Process
Selection of product
Low & high risk
drugs
Solid & liquid
dosage
Soluble & insoluble
ingredients
Sterile & nonsterile
facilities
11
12. EQUIPMENT GROUPING
Can implement C V procedure
Small scale Large scale
Subdivide into
Dedicated &
Non dedicated
Minor & Major
Noncritical &
Critical site
Non product &
product contact
Equipment train
:single &
complex
Equipment selection
Design function
12
14. PERSONNEL TRAINING
Why it is required ?
To understand selection of cleaning parameters
such as time , temperature , cleaning agent
concentration ,sheeting , rinsing .
To evaluate step for removal of residue by
following /understanding SOP’s
Therefore in cleaning validation this is also adds
the same value as other considerations 14
16. ULTRASONIC CLEANING
A process that uses
ultrasound(20-
400kHz)& appropriate
cleaning solvent or
water
Time require for
cleaning generally3-
6nmin & may exeed to
20 min depend upon
object to be clean.
Principle Image
16
17. ULTRASONIC CLEANING
Separates the liq and microscopic
void
Creates compression wave in liq
U.S.Waves fluid changing size &
Ultrasound generating transducer built
into chamber
In a ultrasound chamber
17
18. VAPOR DIGRESSING
Surface finishing
process .
Uses the solvent in the
form of vapor to clean
work piece.
Used where water
based cleaning is
impracticable .
After boiling of solvent
it enters the fill line &
uses spray technique
to clean eupment .
18
19. HOT WATER EXTRACTION
It is a typical
cleaning
method that
uses a
combination of
high water
pressure for
agitation, and
hot water to
increase
reaction rate.
surface is dried to avoid surface saturation
lower the pH of the fibers to a neutral state.
use an acetic acid solution
surface is thoroughly rinse out the preconditioner
light agitation with a grooming brush
preconditioning of the soiled surface with an alkaline agent
19
21. SWAB SAMPLING
The extract examined by a suitable analytical
method
By adding it to dilution solvent
The swab is extracted
A small area of the cleaned equipment is swabbed
21
22. SWAB SAMPLING
Dissolves & physically
remove sample
Adaptable to wide
variety of surfaces
May allow sampling of
defined area
Applicable to active ,
microbial & cleaning
agent residue
An invasive technique
that introduce fiber
Complex & hard to
reach complex areas
Advantages Disadvantages
22
23. RINSE SAMPLING
In rinse sampling API
equipment will be
cleaned by several
washing cycles (runs )
OR cycles/runs
Outline - amount of
residue remaining in the
equipment after cleaning
based on the amount of
residue in the last run of
the routinely used
cleaning procedure.
23
24. RINSE SAMPLING
Allow the sampling of
large surface area
Allow the sampling of
unique (porous)
surfaces
Applicable for actives
,cleaning agent &
exipients
Inability to detect
location of residue
Usually use for rinsing
an entire piece of
equipment
Excess of rinsing
sample is required
Advantages Disadvantages
24
26. ACCEPTANCE CRITERIA
Establishing acceptance limit
Samples should be practical , achievable ,and
verifiable
NMT 10ppm of any product will appear in other
product
NMT 0.1% therapeutic dose of any product will appear
in maximum daily dose of the following product
No quantity of residue should be visible on the
equipment after cleaning procedure are performed
26
27. REPORTS
A validation report is necessary to present the results &
conclusions with approval page duly signed off by
corresponding signatories depicting the approval of
validation study.
It should include :
• Summary of procedures used to clean , sample ,test
• Physical & analytical test results
• Conclusion regarding acceptability of results
• Recommendations based on result
• Review of protocol deviation
• Interim reports till complete study 27
28. DOCUMENTATION
The cleaning process should be documented n an SOP
Documentation should be in such a way that following
information is readily available:
The area or piece of equipment cleaning
The person who carried out the cleaning
When the cleaning was carried out
The SOP defining the cleaning process
The product which was previously processed on the
equipment being cleaned . 28
29. REVALIDATION
It is done if :
• Cleaning procedure is changed
• Raw material are changed
• Change in formulation
• New detergents
• Modification of equipment
To avoid this regular checking is done.
The production manager ,QC manager , QA manager &
whole validation team decide revalidation is necessary or not
.
29
30. CONCLUSION
Cleaning validation is heart of pharmaceutical
industry .
If the proper cleaning is not contamination may
occur in the product & whole process of formulation
hampered by this.
Whole team distribute their work for attending the
cleaning validation process to which QA officer
gives approval based on the overall documented
evidances.
30
31. REFERENCES
S.I.Haider ,E.S .Asif , “Cleaning validation manual
,a comprehensive guide for pharmaceutical
&biotechnogy industries:”,CRC Press
publication,page no -1-30.
Active pharmaceutical ingredients committee
,“Guidance on aspects of cleaning validation in
active pharmaceutical ingredient plants”,december
2008
Andrew walsh , “cleaning validation for 21st
century :the overview of new ISPE cleaning guide
31
32. REFERENCES
S.W.Harder , “validation of cleaning processes”
pharmaceutical technology.(1984)
Sudha T., Krishana Kanth , Nukala Poorana
Chandra Sainath1, Mishal1, Saloman Raja ,
Ganesan , “Method Development and Validation-
A Review”, Journal of Advanced Pharmacy
Education & Research (2012)
32